Difference between revisions of "Event:401"
From AOP-Wiki
Line 17: | Line 17: | ||
!Event Type | !Event Type | ||
!Essentiality | !Essentiality | ||
+ | |||
+ | |- | ||
+ | |||
+ | |[[Aop:8|Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals]]||KE||[[Aop:8#Essentiality of the Key Events|Moderate]] | ||
|- | |- |
Revision as of 16:58, 13 March 2015
Contents
Event Title
Biliary excretion TH glucuronide, Increase
Biliary excretion TH glucuronide, Increase
Key Event Overview
Please follow link to widget page to edit this section.
AOPs Including This Key Event
AOP Name | Event Type | Essentiality |
---|---|---|
Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals | KE | Moderate |
Taxonomic Applicability
Name | Scientific Name | Evidence | Links |
---|
Level of Biological Organization
Biological Organization |
---|
How this Key Event works
How it is Measured or Detected
Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?